EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS133-23420 
Organism
Homo sapiens 
Tissue/cell
melanoma 
Coordinate
chr3:186703130-186705360 
Target genes
Number: 9             
NameEnsembl ID
TF binding sites/motifs
Number: 30             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr3:186704970-186704988GGAGGGAGGGAGGGAGGG+6.03
EWSR1-FLI1MA0149.1chr3:186704939-186704957GGGAGGGAGGAAGAAAGA+6.06
EWSR1-FLI1MA0149.1chr3:186705030-186705048GAAAGAAAGGAAGAAAGA+6.22
EWSR1-FLI1MA0149.1chr3:186704982-186705000GGAGGGAAGGAAAGAAAA+6.33
EWSR1-FLI1MA0149.1chr3:186704935-186704953GGGAGGGAGGGAGGAAGA+6.36
EWSR1-FLI1MA0149.1chr3:186704923-186704941AGAAAGAAGGAAGGGAGG+6.59
EWSR1-FLI1MA0149.1chr3:186704927-186704945AGAAGGAAGGGAGGGAGG+6.71
EWSR1-FLI1MA0149.1chr3:186704974-186704992GGAGGGAGGGAGGGAAGG+6.94
EWSR1-FLI1MA0149.1chr3:186704931-186704949GGAAGGGAGGGAGGGAGG+7.08
EWSR1-FLI1MA0149.1chr3:186704911-186704929GAAAGGAAGGAAAGAAAG+7.36
EWSR1-FLI1MA0149.1chr3:186705021-186705039GGAAGAAAGGAAAGAAAG+7.37
EWSR1-FLI1MA0149.1chr3:186705001-186705019GAAAGAAAGCAAGGAAGG+7.41
EWSR1-FLI1MA0149.1chr3:186704978-186704996GGAGGGAGGGAAGGAAAG+7.62
EWSR1-FLI1MA0149.1chr3:186704915-186704933GGAAGGAAAGAAAGAAGG+7.69
EWSR1-FLI1MA0149.1chr3:186704919-186704937GGAAAGAAAGAAGGAAGG+7.87
EWSR1-FLI1MA0149.1chr3:186705005-186705023GAAAGCAAGGAAGGAAGG+8.03
EWSR1-FLI1MA0149.1chr3:186705009-186705027GCAAGGAAGGAAGGAAGA+8.26
EWSR1-FLI1MA0149.1chr3:186705017-186705035GGAAGGAAGAAAGGAAAG+8.5
EWSR1-FLI1MA0149.1chr3:186705013-186705031GGAAGGAAGGAAGAAAGG+9.25
ZNF263MA0528.1chr3:186704967-186704988CAGGGAGGGAGGGAGGGAGGG+6.02
ZNF263MA0528.1chr3:186704933-186704954AAGGGAGGGAGGGAGGAAGAA+6.03
ZNF263MA0528.1chr3:186705014-186705035GAAGGAAGGAAGAAAGGAAAG+6.11
ZNF263MA0528.1chr3:186705018-186705039GAAGGAAGAAAGGAAAGAAAG+6.21
ZNF263MA0528.1chr3:186704944-186704965GGAGGAAGAAAGAGAAAGAGA+6.36
ZNF263MA0528.1chr3:186704941-186704962GAGGGAGGAAGAAAGAGAAAG+6.42
ZNF263MA0528.1chr3:186704979-186705000GAGGGAGGGAAGGAAAGAAAA+6.4
ZNF263MA0528.1chr3:186704925-186704946AAAGAAGGAAGGGAGGGAGGG+6.65
ZNF263MA0528.1chr3:186704928-186704949GAAGGAAGGGAGGGAGGGAGG+7.38
ZNF263MA0528.1chr3:186704975-186704996GAGGGAGGGAGGGAAGGAAAG+7.41
ZNF263MA0528.1chr3:186704971-186704992GAGGGAGGGAGGGAGGGAAGG+7.63
Number of super-enhancer constituents: 16             
IDCoordinateTissue/cell
SE_07435chr3:186703222-186705601Brain_Hippocampus_Middle_150
SE_10196chr3:186703255-186705590CD19_Primary
SE_10855chr3:186691104-186754774CD20
SE_32534chr3:186703421-186705283GM12878
SE_33923chr3:186703461-186704195HCC1954
SE_40708chr3:186703316-186704840Left_Ventricle
SE_42364chr3:186703983-186704765Lung
SE_43633chr3:186703125-186707978MM1S
SE_48802chr3:186704004-186704697Right_Atrium
SE_58288chr3:186627032-186791622Ly1
SE_59164chr3:186703252-186764260Ly3
SE_60441chr3:186703232-186762793DHL6
SE_61008chr3:186703204-186764166HBL1
SE_62186chr3:186703447-186763111Toledo
SE_62245chr3:186702797-186764702Tonsil
SE_67440chr3:186703125-186707978MM1S
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr3186704800186704868
chr3186705053186705317
Number: 2             
IDChromosomeStartEnd
GH03I186985chr3186703189186704944
GH03I186987chr3186704989186705188
Enhancer Sequence
GTTGATCTTC ATCTGGGTTA TTCACTGTAG TATCCTATGC ACTAAGAATT ATACTTAGCA 60
CTTAGCAAAT GTTTAATACA TTTTTTTTTA AAGTGAGTAA GCGTAGAATA TAAAGCTTTT 120
GTGCAGGTCT CTAAAAGTTT TTGAAAGGAT ATGATCTGAG GCTAGGCACT CCCAGCACTT 180
TGGGAAGTCA AGGTGGGTGC ATCTTGAGCT CAGAAGTTCG AGATTAGCCT GGGAAACATG 240
GCGAAACCCC GTCTCTTCAA AAAGTAAAAA AAAAAAAAAA AAATTAGCTG GTCCTGGTGG 300
AGCATGCCTA TAGTCCCAGC TACTCAGGAA GCTGAGGAGG GACGATTGCT TGAGCCTCAG 360
AGGTGGACGT TGCAGTGAGC CGAGATTGCG CCACTGCGCT CCAGCCTGGG TGGCAGAGTG 420
AGACCCTGTC TCAAAAAAAA AAAAAGAAAA AAGAAAAAGA AAAAAAGACG AGGTCTGGAG 480
TCTGAGGGAG ATGTCACTGG GGGCTGGTCA TGTGGAAGCA GGAATCTTCC CCGTGTATGT 540
GGGCATTTCA GGACTGGCAG GAAGCTGGTC CCAGGGGAGG CTAAGCTGGG GAGGATGCCT 600
GAAAGGCATT AGTGGGAGGG AGTTTGAAAA AGACCCAGAG ACGCCTGTTT GAAATAAGTA 660
TTGGAAAGGA CTCTTTAGAT TTTGCAATTA GAAAGGCAGT TTCAGTGGAA TGATGTGAAC 720
CGACTTCAGT TATTTGAGGA ACCAGTAGAA AGTGGGGAAG TGTAAGCAAG TCAAGAGACC 780
CCGCCATAAG GAAGCAGAGA TTAGGTTGCC GTTTGAGGAA GTGATTTGTT TGAGGTATTT 840
TTTTTTAGCT CCACAAAATA TCATGTTTCG GGTGTGAGTA GGGATGGGGT AAATGACACA 900
CTAAGCTAAT AACATCCAAA CCAGCTTGTG AAACATCGTG CAAGTTATAT CTGGTTCATA 960
CCAAAGAGTC GCTACTCAGT CCAGGCCTCT ATCATGCCTG GCACATAGTG TTGAATATTG 1020
TATTCAATAA ATATTCAACA GTAAATATTT GTTGAATACA GTATTAAATA CTATAGAATT 1080
TAGACAGGTC CCTGTATCAA CAACAGCAAC AATGACCACC ACCACCACCA CCACCACCAC 1140
AACAAAATAA CAAGAATGTC CAATGTAGGG GGTTGCTTTT TGATCCACTT GCCTTTGGCT 1200
AGTGGTGTCT TTCTCTCCTT AGCGCCATAT TCTTCAGCAC TTTTCGGCAG CTGTATGTGG 1260
TTCTATTTTG GTCTCCTCTT TACTGCACGG CGATTATGTT TTCAAGAGGC AAATCTTCAG 1320
GGTGACTAGA GTGACACGTT ATCTGAGTTC TGGATGGAGG TAAAGGAATA TCACGGTGAG 1380
TCTGGGGAAG CAAGGGGACA AGAGAGTTGG CCAAATGAGG CGGAAAGACC CCAGACTTGC 1440
GATCAGAAGA ACCTGATGTC AAATCAGATG CATCTTATAG CAAGTCGAGC CACCTCTCTG 1500
AAACTTGAAT TTAAATGATC TAAGGTCATT TCCTTTGGAT TTTATAGAAA GAATAGTGTC 1560
AGGAGAAAAA GAAAAACAAG GAACCATGAC TTGCTAAACA TACTCAGAAC CAAAGGTTTT 1620
CTTTCTTTCC TTTTAAAAAA AAGTGATATA CAGTGAATAC AGGCTTAGTT CCCTAATGGT 1680
GGCAAATGAT GTAATGTTCA CAGATGTCCT GGGGGAAAAC AGAACAATCA ACTTCTATTT 1740
TACTCTTACC ATTTCTGAGA GAAGTCAGGC AGACTGCATA GGAAAGGAAG GAAAGAAAGA 1800
AGGAAGGGAG GGAGGGAGGA AGAAAGAGAA AGAGAGACAG GGAGGGAGGG AGGGAGGGAA 1860
GGAAAGAAAA GGAAAGAAAG CAAGGAAGGA AGGAAGAAAG GAAAGAAAGG AAGAAAGAAA 1920
GAAGAAAGAA AAGCCCCTAA GGTTAGTAAG TATCTTATGT CCCTGGAACT ACGCTAGGCA 1980
CATACATACC TTACCACCTT CCTTATCCAG TGAAGGGTAT TACATCAGTG TTTTAGGTAA 2040
CCTACCCAAG GTCCACAGCT AACAATGGGG AGAGAGGATA CAACAAGCCT TTGGGGGAGA 2100
AAATTGAAGC CCACGGCCCA CAAGAAATAA AGCCAAGAAA TGTAGTTGCT TAAAGTCAGC 2160
CAGATTCCCC AGCACCCAGC ATAGTGTCTT ATTCTTAGGA GAATTTGAGA AATATTTATT 2220
TATCTAAGGG 2230